Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | MYLK | Q15746 | 2/20 | 0.46 |
| ▸ | PRKCG | P05129 | 1/20 | 0.46 |
| ▸ | PRKCA | P17252 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3706484 | 0.86 | ALDH1A1 (0.46) | ALDH1A1MAPTPRKCEMEN1KMT2A | |
| SCHEMBL5513040 | 0.79 | CA2 (0.41) | ALDH1A1MAPTPRKCEMEN1KMT2A | |
| SCHEMBL15413361 | 0.78 | ALDH1A1 (0.48) | ALDH1A1MAPTPRKCEMEN1KMT2A | |
| SCHEMBL6057485 | 0.75 | ALDH1A1 (0.46) | ALDH1A1MAPTPRKCEMEN1KMT2A | |
| SCHEMBL12309156 | 0.75 | HSPA5 (0.68) | ALDH1A1MAPTPRKCEMEN1KMT2A | |
| SCHEMBL38917 | 0.73 | CA2 (0.55) | ALDH1A1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL5587534 | 0.72 | ALOX15 (0.55) | ALDH1A1MAPTMEN1KMT2ACA2 | |
| SCHEMBL30631016 | 0.71 | ALDH1A1 (0.39) | ALDH1A1MAPTPRKCEMEN1KMT2A | |
| SCHEMBL11366818 | 0.71 | PRKCE (0.44) | ALDH1A1MAPTPRKCEMEN1KMT2A | |
| SCHEMBL14000559 | 0.70 | HSPA5 (0.67) | ALDH1A1MAPTPRKCEMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | NUTECH VENTURES | 2016-10-27 | — | — | US | disclosed |
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | NUTECH VENTURES | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160310528-A1 | Castration-Resistant Prostate Cancer | UGDH, G6PD, DPYD | ALDH1A1 54/4885MAPT 2722/4885PRKCE 3085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.